Sharp Douglas J, Senior Managing Director, has demonstrated a consistent pattern of selling activity in Invesco Ltd. (IVZ) shares, as evidenced by SEC Form 4 filings. Over the course of 28 transactions, Sharp has exclusively sold shares, with no recorded purchases, resulting in a total sell value of approximately $5.8 million. This activity spans multiple years, with notable transactions including a significant sale of $3.77 million on October 31, 2025, and smaller but consistent sales throughout 2025 and 2026. For instance, on February 28, 2026, Sharp sold shares valued at $569,448.10, following earlier sales of $403,201.41 on January 15, 2026, and $230,501.70 on August 31, 2025. These transactions, often accompanied by derivative transactions marked as "A" or "M" with no reported value, suggest a strategic reduction in holdings rather than sporadic disposals.
The absence of any buying activity indicates a clear bias toward divestment in IVZ shares. Sharp’s recent filings, including a sale of $569,448.10 on February 28, 2026, reinforce this trend. The consistency and timing of these sales, particularly the larger transactions in late 2025, highlight a deliberate approach to reducing exposure to IVZ. While the filings do not provide context for the transactions, the data underscores Sharp’s ongoing disengagement from Invesco Ltd. through systematic sales over an extended period. This pattern aligns with a broader strategy of portfolio adjustment, as reflected in the cumulative sell value and the absence of any acquisition activity.
AI-assisted summary